메뉴 건너뛰기




Volumn 48, Issue 3, 2007, Pages 535-541

Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: Analysis of prognostic factors and comparison with a single procedure

Author keywords

Hodgkin lymphoma; Second autologous transplant

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

EID: 33947692738     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601158621     Document Type: Article
Times cited : (6)

References (27)
  • 1
    • 0027404777 scopus 로고
    • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
    • Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B. and McMillan, A. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet, 341, pp. 1051-1054.
    • (1993) Lancet , vol.341 , pp. 1051-1054
    • Linch, D.C.1    Winfield, D.2    Goldstone, A.H.3    Moir, D.4    Hancock, B.5    McMillan, A.6
  • 2
    • 0030938978 scopus 로고    scopus 로고
    • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
    • Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Long, G. D. and Hu, W. W. (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. Blood, 89, pp. 801-813.
    • (1997) Blood , vol.89 , pp. 801-813
    • Horning, S.J.1    Chao, N.J.2    Negrin, R.S.3    Hoppe, R.T.4    Long, G.D.5    Hu, W.W.6
  • 3
    • 0032895067 scopus 로고    scopus 로고
    • Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: A case-control study
    • Societe Francaise de Greffe de Moelle
    • Andre, M., Henry-Amar, M., Pico, J. L., Brice, P., Blaise, D. and Kuentz, M. (1999) Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: A case-control study. Societe Francaise de Greffe de Moelle. J Clin Oncol, 17, pp. 222-229.
    • (1999) J Clin Oncol , vol.17 , pp. 222-229
    • Andre, M.1    Henry-Amar, M.2    Pico, J.L.3    Brice, P.4    Blaise, D.5    Kuentz, M.6
  • 4
    • 0030942265 scopus 로고    scopus 로고
    • Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
    • Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., Halpern, J. D. and Horning, S. J. (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood, 89, pp. 814-822.
    • (1997) Blood , vol.89 , pp. 814-822
    • Yuen, A.R.1    Rosenberg, S.A.2    Hoppe, R.T.3    Halpern, J.D.4    Horning, S.J.5
  • 5
    • 0032887877 scopus 로고    scopus 로고
    • High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation
    • Lymphoma Working Party
    • Sweetenham, J. W., Carella, A. M., Taghipour, G., Cunningham, D., Marcus, R. and Della Volpe, A. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. J Clin Oncol, 17, pp. 3101-3109.
    • (1999) J Clin Oncol , vol.17 , pp. 3101-3109
    • Sweetenham, J.W.1    Carella, A.M.2    Taghipour, G.3    Cunningham, D.4    Marcus, R.5    Della Volpe, A.6
  • 6
    • 0030710532 scopus 로고    scopus 로고
    • High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: Results from the EBMT
    • Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    • Sweetenham, J. W., Taghipour, G., Milligan, D., Blystad, A. K., Caballero, D., Fassas, A. and Goldstone, A. H. (1997) High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: Results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant, 20, pp. 745-752.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 745-752
    • Sweetenham, J.W.1    Taghipour, G.2    Milligan, D.3    Blystad, A.K.4    Caballero, D.5    Fassas, A.6    Goldstone, A.H.7
  • 7
    • 0036265402 scopus 로고    scopus 로고
    • Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease
    • Josting, A., Engert, A., Diehl, V. and Canellos, G. P. (2002) Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease. Ann Oncol, 13, pp. 112-116.
    • (2002) Ann Oncol , vol.13 , pp. 112-116
    • Josting, A.1    Engert, A.2    Diehl, V.3    Canellos, G.P.4
  • 8
    • 19944426729 scopus 로고    scopus 로고
    • Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
    • Josting, A., Rudolph, C., Mapara, M., Glossmann, J. P., Sienawski, M. and Sieber, M. (2005) Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol, 16, pp. 116-123.
    • (2005) Ann Oncol , vol.16 , pp. 116-123
    • Josting, A.1    Rudolph, C.2    Mapara, M.3    Glossmann, J.P.4    Sienawski, M.5    Sieber, M.6
  • 10
    • 0037097044 scopus 로고    scopus 로고
    • Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
    • Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A. M. and Haenel, M. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet, 359, pp. 2065-2071.
    • (2002) Lancet , vol.359 , pp. 2065-2071
    • Schmitz, N.1    Pfistner, B.2    Sextro, M.3    Sieber, M.4    Carella, A.M.5    Haenel, M.6
  • 11
    • 0035281922 scopus 로고    scopus 로고
    • Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/ Transplante Autologo de Medula Osea Spanish Cooperative Group
    • Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J. J. and Garcia-Conde, J. (2001) Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol, 19, pp. 1395-1404.
    • (2001) J Clin Oncol , vol.19 , pp. 1395-1404
    • Sureda, A.1    Arranz, R.2    Iriondo, A.3    Carreras, E.4    Lahuerta, J.J.5    Garcia-Conde, J.6
  • 12
    • 20944446433 scopus 로고    scopus 로고
    • Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
    • Sureda, A., Constans, M., Iriondo, A., Arranz, R., Caballero, M. D. and Vidal, M. J. (2005) Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol, 16, pp. 625-633.
    • (2005) Ann Oncol , vol.16 , pp. 625-633
    • Sureda, A.1    Constans, M.2    Iriondo, A.3    Arranz, R.4    Caballero, M.D.5    Vidal, M.J.6
  • 13
    • 0037767208 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome
    • Constans, M., Sureda, A., Terol, M. J., Arranz, R., Caballero, M. D. and Iriondo, A. (2003) Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome. Ann Oncol, 14, pp. 745-751.
    • (2003) Ann Oncol , vol.14 , pp. 745-751
    • Constans, M.1    Sureda, A.2    Terol, M.J.3    Arranz, R.4    Caballero, M.D.5    Iriondo, A.6
  • 14
    • 4444382093 scopus 로고    scopus 로고
    • Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: A study of 341 patients
    • Czyz, J., Dziadziuszko, R., Knopinska-Postuszuy, W., Hellmann, A., Kachel, L. and Holowiecki, J. (2004) Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: A study of 341 patients. Ann Oncol, 15, pp. 1222-1230.
    • (2004) Ann Oncol , vol.15 , pp. 1222-1230
    • Czyz, J.1    Dziadziuszko, R.2    Knopinska-Postuszuy, W.3    Hellmann, A.4    Kachel, L.5    Holowiecki, J.6
  • 15
    • 0036049779 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease
    • Czyz, J., Hellmann, A., Dziadziuszko, R., Hansz, J., Gozdzik, J. and Holowiecki, J. (2002) High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group. Bone Marrow Transplant, 30, pp. 29-34.
    • (2002) Bone Marrow Transplant , vol.30 , pp. 29-34
    • Czyz, J.1    Hellmann, A.2    Dziadziuszko, R.3    Hansz, J.4    Gozdzik, J.5    Holowiecki, J.6
  • 16
    • 23744515284 scopus 로고    scopus 로고
    • High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: Long-term outcome in the first 100 patients treated in Vancouver
    • Lavoie, J. C., Connors, J. M., Phillips, G. L., Reece, D. E., Barnett, M. J. and Forrest, D. L. (2005) High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: Long-term outcome in the first 100 patients treated in Vancouver. Blood, 106, pp. 1473-1478.
    • (2005) Blood , vol.106 , pp. 1473-1478
    • Lavoie, J.C.1    Connors, J.M.2    Phillips, G.L.3    Reece, D.E.4    Barnett, M.J.5    Forrest, D.L.6
  • 17
    • 20144367598 scopus 로고    scopus 로고
    • Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Lymphoma Study Group
    • Josting, A., Nogova, L., Franklin, J., Glossmann, J. P., Eich, H. T. and Sieber, M. (2005) Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol, 23, pp. 1522-1529.
    • (2005) J Clin Oncol , vol.23 , pp. 1522-1529
    • Josting, A.1    Nogova, L.2    Franklin, J.3    Glossmann, J.P.4    Eich, H.T.5    Sieber, M.6
  • 19
    • 0030008082 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
    • European Group for Blood and Bone Marrow Transplantation
    • Milpied, N., Fielding, A. K., Pearce, R. M., Ernst, P. and Goldstone, A. H. (1996) Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. J Clin Oncol, 14, pp. 1291-1296.
    • (1996) J Clin Oncol , vol.14 , pp. 1291-1296
    • Milpied, N.1    Fielding, A.K.2    Pearce, R.M.3    Ernst, P.4    Goldstone, A.H.5
  • 20
    • 1142310687 scopus 로고    scopus 로고
    • Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin's disease: Indications and results
    • Schmitz, N., Sureda, A. and Robinson, S. (2004) Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin's disease: Indications and results. Semin Oncol, 31, pp. 27-32.
    • (2004) Semin Oncol , vol.31 , pp. 27-32
    • Schmitz, N.1    Sureda, A.2    Robinson, S.3
  • 21
    • 0034554782 scopus 로고    scopus 로고
    • Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma
    • Carella, A. M., Cavaliere, M., Lerma, E., Ferrara, R., Tedeschi, L. and Romanelli, A. (2000) Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol, 18, pp. 3918-3924.
    • (2000) J Clin Oncol , vol.18 , pp. 3918-3924
    • Carella, A.M.1    Cavaliere, M.2    Lerma, E.3    Ferrara, R.4    Tedeschi, L.5    Romanelli, A.6
  • 22
    • 0033371462 scopus 로고    scopus 로고
    • Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)
    • SFGM/GELA Study Group
    • Brice, P., Divine, M., Simon, D., Coiffier, B., Leblond, V. and Simon, M. (1999) Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study Group. Ann Oncol, 10, pp. 1485-1488.
    • (1999) Ann Oncol , vol.10 , pp. 1485-1488
    • Brice, P.1    Divine, M.2    Simon, D.3    Coiffier, B.4    Leblond, V.5    Simon, M.6
  • 23
    • 3242703317 scopus 로고    scopus 로고
    • Treatment for primary refractory Hodgkin's disease: A comparison of high-dose chemotherapy followed by ASCT with conventional therapy
    • Czyz, J., Szydlo, R., Knopinska-Posluszny, W., Hellmann, A., Gozdzik, J. and Hansz, J. (2004) Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy. Bone Marrow Transplant, 33, pp. 1225-1229.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 1225-1229
    • Czyz, J.1    Szydlo, R.2    Knopinska-Posluszny, W.3    Hellmann, A.4    Gozdzik, J.5    Hansz, J.6
  • 24
    • 0347815503 scopus 로고    scopus 로고
    • Single versus double autologous stem-cell transplantation for multiple myeloma
    • Attal, M., Harousseau, J. L., Facon, T., Guilhot, F., Doyen, C. and Fuzibet, J. G. (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med, 349, pp. 2495-2502.
    • (2003) N Engl J Med , vol.349 , pp. 2495-2502
    • Attal, M.1    Harousseau, J.L.2    Facon, T.3    Guilhot, F.4    Doyen, C.5    Fuzibet, J.G.6
  • 25
    • 0032881730 scopus 로고    scopus 로고
    • Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma
    • Fitoussi, O., Simon, D., Brice, P., Makke, J., Scrobohaci, M. L. and Triki, T Bibi (1999) Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant, 24, pp. 747-755.
    • (1999) Bone Marrow Transplant , vol.24 , pp. 747-755
    • Fitoussi, O.1    Simon, D.2    Brice, P.3    Makke, J.4    Scrobohaci, M.L.5    Bibi Triki, T.6
  • 27
    • 0031040310 scopus 로고    scopus 로고
    • Single and double autotransplants for relapsing/refractory Hodgkin's disease: Results of two consecutive trials
    • Ahmed, T., Lake, D. E., Beer, M., Feldman, E. J., Preti, R. A. and Seiter, K. (1997) Single and double autotransplants for relapsing/ refractory Hodgkin's disease: Results of two consecutive trials. Bone Marrow Transplant, 19, pp. 449-454.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 449-454
    • Ahmed, T.1    Lake, D.E.2    Beer, M.3    Feldman, E.J.4    Preti, R.A.5    Seiter, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.